Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects

Biochemical and Biophysical Research Communications

Volumn 382, Issue 4, 2009, Pages 766-770

  Gaster, Michael ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Human; Insulin resistance; Lipid oxidation; Lipotoxicity; Myotubes; Obesity; Skeletal muscle; Type 2 diabetes

Indexed keywords

LIPID; PALMITIC ACID;

ADULT; ARTICLE; CITRIC ACID CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FATTY ACID OXIDATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID OXIDATION; LIPOLYSIS; MITOCHONDRION; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE;

CELL DIFFERENTIATION; CELL LINE; DIABETES MELLITUS, TYPE 2; HUMANS; LIPID METABOLISM; LIPOLYSIS; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; OBESITY; OXIDATION-REDUCTION; PALMITATES;

EID: 64549139279     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.102     Document Type: Article

References (28)

1. Gaster M. The dynamic of lipid oxidation in human myotubes. Biochim. Biophys. Acta 1791 (2009) 17-24
2. Gaster M., Rustan A.C., Aas V., and Beck-Nielsen H. Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes. Diabetes 53 (2004) 542-548
3. Gaster M., Rustan A., and Beck-Nielsen H. Differential utilization of saturated palmitate and unsaturated oleate. Evidence from cultured myotubes. Diabetes 54 (2005) 648-656
4. Wensaas A.J., Rustan A.C., Just M., Berge R.K., Drevon C.A., and Gaster M. Fatty acid incubation of myotubues from humans with type 2 diabetes leads to enhanced release of beta oxidation products due to impaired fatty acid oxidation: effects of tetradecylthioacetic acid and eicosapentaenoic acid. Diabetes 58 (2009) 527-535
5. Koves T.R., Ussher J.R., Noland R.C., Slentz D., Mosedale M., Ilkayeva O., Bain J., Stevens R., Dyck J.R., Newgard C.B., Lopaschuk G.D., and Muoio D.M. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7 (2008) 45-56
6. Gaster M., Petersen I., Hojlund K., Poulsen P., and Beck-Nielsen H. The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes 51 (2002) 921-927
7. Gaster M., Kristensen S.R., Beck-Nielsen H., and Schroder H.D. A cellular model system of differentiated human myotubes. APMIS 109 (2001) 735-744
8. Gaster M., and Beck-Nielsen H. Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects. Biochim. Biophys. Acta 1761 (2006) 100-110
9. Gaster M. Metabolic flexibility is conserved in diabetic myotubes. J. Lipid Res. 48 (2007) 207-217
10. Ortenblad N., Mogensen M., Petersen I., Hojlund K., Levin K., Sahlin K., Beck-Nielsen H., and Gaster M. Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect. Biochim. Biophys. Acta 1741 (2005) 206-214
11. Gaster M., Schroder H.D., Handberg A., and Beck-Nielsen H. The basal kinetic parameters of glycogen synthase in human myotube cultures are not affected by chronic high insulin exposure. Biochim. Biophys. Acta 1537 (2001) 211-221
12. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
13. Wensaas A.J., Rustan A.C., Lovstedt K., Kull B., Wikstrom S., Drevon C.A., and Hallen S. Cell-based multiwell assays for the detection of substrate accumulation and oxidation. J. Lipid Res. 48 (2007) 961-967
14. Skrede S., Bremer J., Berge R.K., and Rustan A.C. Stimulation of fatty acid oxidation by a 3-thia fatty acid reduces triacylglycerol secretion in cultured rat hepatocytes. J. Lipid Res. 35 (1994) 1395-1404
15. Tarnopolsky M.A., Rennie C.D., Robertshaw H.A., Fedak-Tarnopolsky S.N., Devries M.C., and Hamadeh M.J. Influence of endurance exercise training and sex on intramyocellular lipid and mitochondrial ultrastructure, substrate use, and mitochondrial enzyme activity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292 (2007) R1271-R1278
16. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., Houstis N., Daly M.J., Patterson N., Mesirov J.P., Golub T.R., Tamayo P., Spiegelman B., Lander E.S., Hirschhorn J.N., Altshuler D., and Groop L.C. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34 (2003) 267-273
17. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E.J., Goldfine A.B., Mun E., DeFronzo R., Finlayson J., Kahn C.R., and Mandarino L.J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. USA 100 (2003) 8466-8471
18. Kelley D.E., He J., Menshikova E.V., and Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51 (2002) 2944-2950
19. Schrauwen-Hinderling V.B., Roden M., Kooi M.E., Hesselink M.K., and Schrauwen P. Muscular mitochondrial dysfunction and type 2 diabetes mellitus. Curr. Opin. Clin. Nutr. Metab. Care 10 (2007) 698-703
20. Schrauwen-Hinderling V.B., Kooi M.E., Hesselink M.K., Jeneson J.A., Backes W.H., van Echteld C.J., van Engelshoven J.M., Mensink M., and Schrauwen P. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50 (2007) 113-120
21. Ritov V.B., Menshikova E.V., He J., Ferrell R.E., Goodpaster B.H., and Kelley D.E. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54 (2005) 8-14
22. Mogensen M., Sahlin K., Fernstrom M., Glintborg D., Vind B.F., Beck-Nielsen H., and Hojlund K. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 56 (2007) 1592-1599
23. Petersen K.F., Dufour S., Befroy D., Garcia R., and Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350 (2004) 664-671
24. Befroy D.E., Petersen K.F., Dufour S., Mason G.F., de Graaf R.A., Rothman D.L., and Shulman G.I. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes 56 (2007) 1376-1381
25. Gaster M. Insulin resistance and the mitochondrial link. Lessons from cultured human myotubes. Biochim. Biophys. Acta 1772 (2007) 755-765
26. Dresner A., Laurent D., Marcucci M., Griffin M.E., Dufour S., Cline G.W., Slezak L.A., Andersen D.K., Hundal R.S., Rothman D.L., Petersen K.F., and Shulman G.I. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J. Clin. Invest. 103 (1999) 253-259
27. Griffin M.E., Marcucci M.J., Cline G.W., Bell K., Barucci N., Lee D., Goodyear L.J., Kraegen E.W., White M.F., and Shulman G.I. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48 (1999) 1270-1274
28. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., Bergeron R., Kim J.K., Cushman S.W., Cooney G.J., Atcheson B., White M.F., Kraegen E.W., and Shulman G.I. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277 (2002) 50230-50236